Deficiency of Erbin induces resistance of cervical cancer cells to anoikis in a STAT3-dependent manner
Open Access
- 17 June 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogenesis
- Vol. 2 (6), e52
- https://doi.org/10.1038/oncsis.2013.18
Abstract
Epithelial cell polarization and integration are essential to their function and loss of epithelial polarity and tissue architecture correlates with the development of aggressive tumors. Erbin is a basolateral membrane-associated protein. The roles of Erbin in establishing cell polarization and regulating cell adhesion have been suggested. Erbin is also a negative regulator in Ras-Raf-ERK (extracellular signal-regulated kinase) signaling pathway. However, the potential functions of Erbin in human cancer are basically unknown. In the present study, we show, for the first time, that loss of Erbin endows cervical cancer cells with resistance to anoikis both in vitro and in vivo and promotes the growth and metastasis of human cervical cancer xenografts in nude mice. We found that knockdown of Erbin induced the phosphorylation, nuclear translocation and transcriptional activities of signal transducer and activator of transcription factor 3 (STAT3) in cervical cancer cells. Overexpression of STAT3C or induction of endogenous STAT3 activation by interleukin (IL)-6 evidently inhibited anoikis of cervical cancer cells, whereas WP1066, a potent inhibitor of Janus-activated kinase 2 (Jak2)/STAT3, effectively blocked the effect of Erbin knockdown on cell survival under anchorage-independent conditions, indicating that loss of Erbin confers resistance of cervical cancer cells to anoikis in a STAT3-dependent manner. Interestingly, IL-6 induced STAT3 activation and Erbin expression simultaneously. Overexpression of STAT3C also significantly upregulated the level of Erbin, whereas the Jak2 inhibitor AG490 remarkably blocked not only STAT3 phosphorylation but also IL-6-induced Erbin expression. Knockdown of Erbin augmented the effects of IL-6 on STAT3 activation and anoikis resistance. In addition, by immunohistochemical analysis of Erbin expression, we demonstrate that the expression of Erbin is significantly decreased or even lost in cervical cancer tissues. These data reveal that Erbin is a novel negative regulator of STAT3, and the IL-6/STAT3/Erbin loop has a crucial role in cervical cancer progression and metastasis.Keywords
This publication has 60 references indexed in Scilit:
- Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiationJCI Insight, 2013
- SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasiaJCI Insight, 2011
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Interaction between RasV12 and scribbled clones induces tumour growth and invasionNature, 2010
- Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinomaBritish Journal of Cancer, 2009
- Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in CarcinomaCell, 2008
- Erbin Inhibits Transforming Growth Factor β Signaling through a Novel Smad-Interacting DomainMolecular and Cellular Biology, 2007
- Stat3 activation in human endometrial and cervical cancersBritish Journal of Cancer, 2007
- Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentNature Reviews Immunology, 2007
- Role for Erbin in Bacterial Activation of Nod2Infection and Immunity, 2006